ALLISON DERTOUZOS: Open Payments
NPI 1669146965 · LAWRENCEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 29 payments from 7 companies in 2025. Trend: 2023 $520 · 2024 $576 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $155 |
| Phathom Pharmaceuticals, Inc. | 1 | $110 |
| Hikma Pharmaceuticals USA | 6 | $90 |
| GENZYME CORPORATION | 5 | $90 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Optinose US, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: DUPIXENT, VOQUEZNA, Ryaltris, NUCALA, Xhance, TEZSPIRE.
Industry payments across NJ — which companies pay providers there.
